Effect of topical mesalazine over adenomas incidence in rectal stumps and ileal pouches of familial adenomatous polyposis patients submitted to colectomy.

ABSTRACT: Interventions: Mesalazine, 1g per day of rectal foam, for 12months Primary outcome(s): New adenomas (larger than 5mm) incidence in the rectal stumps or ileal pouches, as assessed by endoscopy[At study entry and six and twelve months after mesalazine use] Study Design: Purpose: Prevention; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group;Type of endpoint: Efficacy

DISEASE(S): Oral And Gastrointestinal-other Diseases Of The Mouth, Teeth, Oesophagus, Digestive System Including Liver And Colon,Adenomas Incidence In Rectal Stumps And Ileal Pouches,Human Genetics And Inherited Disorders-other Human Genetics And Inherited Disorders,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon),Familial Adenomatous Polyposis

PROVIDER: 2457717 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR